Contemporary trends in oral antiplatelet agent use in patients treated with percutaneous coronary intervention for acute coronary syndrome K Kim, TA Lee, DR Touchette, RJ DiDomenico, AK Ardati, SM Walton Journal of managed care & specialty pharmacy 23 (1), 57-63, 2017 | 44 | 2017 |
Clinical Utility of Pharmacogenetic Testing and a Clinical Decision Support Tool to Enhance the Identification of Drug Therapy Problems Through Medication Therapy Management in … K Kim, JW Magness, R Nelson, V Baron, DI Brixner Journal of managed care & specialty pharmacy 24 (12), 1250-1259, 2018 | 43 | 2018 |
The potential impact of monitoring disease activity biomarkers on rheumatoid arthritis outcomes and costs GM Oderda, GD Lawless, GC Wright, SR Nussbaum, R Elder, K Kim, ... Personalized medicine 15 (04), 291-301, 2018 | 21 | 2018 |
Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome K Kim, DR Touchette, LH Cavallari, AK Ardati, RJ DiDomenico Cardiovascular drugs and therapy, 1-14, 2019 | 16 | 2019 |
The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring AE Jones, JB King, K Kim, DM Witt Journal of thrombosis and thrombolysis 50 (3), 739-745, 2020 | 13 | 2020 |
Assessing patient preferences for switching from warfarin to direct oral anticoagulants JN Wright, SR Vazquez, K Kim, AE Jones, DM Witt Journal of thrombosis and thrombolysis, 1-7, 2019 | 13 | 2019 |
Tetrodotoxin‐Sensitive Neuronal‐Type Na+ Channels: A Novel and Druggable Target for Prevention of Atrial Fibrillation MA Munger, Y Olğar, ML Koleske, HL Struckman, J Mandrioli, Q Lou, ... Journal of the American Heart Association 9 (11), e015119, 2020 | 12 | 2020 |
Effect of food on systemic exposure to niflumic acid following postprandial administration of talniflumate W Kang, K Kim, EY Kim, K Kwon, JS Bang, YR Yoon European journal of clinical pharmacology 64 (10), 1027-1030, 2008 | 12 | 2008 |
Comparative effectiveness of oral antiplatelet agents in patients with acute coronary syndrome K Kim, TA Lee, AK Ardati, RJ DiDomenico, DR Touchette, SM Walton Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (8 …, 2017 | 10 | 2017 |
Stroke diagnosis associated with thrombophilia testing overutilization. K Kim, N Cox, DM Witt Thrombosis research 157, 139, 2017 | 9 | 2017 |
Determination of talniflumate and niflumic acid in human plasma by liquid chromatography-tandem mass spectrometry W Kang, K Kim Analytical Sciences 25 (4), 571-574, 2009 | 8 | 2009 |
Consumer awareness and utilization of clinical services, and their satisfaction and loyalty with community pharmacies: Analysis of a US nationwide survey Tavan Parker, Casey R Tak, Kibum Kim, Michael Feehan, Mark A Munger Journal of American College of Clinical Pharmacy, 2019 | 7 | 2019 |
Influence of Treatment Intensification on A1c in Patients with Suboptimally Controlled Type 2 Diabetes After 2 Oral Antidiabetic Agents K Kim, S Unni, C McAdam-Marx, SM Thomas, KL Sterling, CJ Olsen, ... Journal of managed care & specialty pharmacy 25 (3), 314-322, 2019 | 7 | 2019 |
Considering Recent Trends in Healthcare Labor Markets in Educational Program Planning in Allied Health SM Walton, K Kim, SJ Weiner Journal of allied health 46 (3), 197-202, 2017 | 7 | 2017 |
Providers' utilization and perceptions of warfarin dosing algorithms T Gardner, SR Vazquez, K Kim, AE Jones, DM Witt Thrombosis research 183, 4-12, 2019 | 6 | 2019 |
Comparison of 6-Month Costs Between Oral Antiplatelet Agents Following Acute Coronary Syndrome K Kim, TA Lee, DR Touchette, RJ DiDomenico, AK Ardati, SM Walton Journal of managed care & specialty pharmacy 24 (8), 800-812, 2018 | 5 | 2018 |
Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes K Kim, S Unni, DI Brixner, SM Thomas, CJ Olsen, KL Sterling, M Mitchell, ... Diabetes, Obesity and Metabolism 21 (7), 1725-1733, 2019 | 4 | 2019 |
Cost-Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Patients with Chronic Myeloid Leukemia K Kim, B Walker, GA McMillin, PS Bernard, RL Schmidt Value in Health 21, S125-S126, 2018 | 4 | 2018 |
Quantitative Determination of Octylonium in Human Plasma by LC–MS K Kim, H Jung, HY Yun, SO Moon, YR Yoon, K Kwon, H Kim, S Shon, ... Chromatographia 66 (3-4), 257-260, 2007 | 4 | 2007 |
Patient Satisfaction With Venous Thromboembolism Treatment D Webb, K Kim, CR Tak, DM Witt, M Feehan, MA Munger Clinical and Applied Thrombosis/Hemostasis 25, 1076029619864663, 2019 | 3 | 2019 |